Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung CancerNitin Roper, Udayan Guha, Christopher Trindade et al.|Cell Reports Medicine|2020Cited by 186
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S. Reardon, David S. Schrump, Vivek Shukla et al.|Journal of Thoracic Oncology|2020Cited by 38